Henry, N Lynn <br/><br/>
Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry.  [electronic resource] 

 -  Cancer  05 2017 
 - 948-956 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.30429  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor<br/>Breast Neoplasms--diagnosis<br/>Clinical Decision-Making<br/>Female<br/>Gene Expression Profiling--methods<br/>Genetic Testing<br/>Humans<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--genetics<br/>Neoplasm Staging<br/>Prognosis<br/>Registries